What is Springtide Child Development?
Headquartered in New York City, Springtide Child Development operates as a sophisticated multi-site practice dedicated to the treatment of children with developmental disabilities. By integrating evidence-based therapeutic interventions with a scalable clinical model, the company addresses critical gaps in the behavioral health landscape. Its market position is defined by a commitment to high-quality, accessible care, effectively bridging the divide between traditional clinical settings and modern, patient-centric healthcare delivery systems.
How much funding has Springtide Child Development raised?
Springtide Child Development has raised a total of $18.1M across 1 funding round:
Series A
$18.1M
Series A (2020): $18.1M with participation from Optum Ventures and Deerfield Communications Inc
Key Investors in Springtide Child Development
Optum Ventures
A venture capital firm focused on investing in early-stage companies that aim to disrupt the healthcare status quo and improve patient outcomes.
Deerfield Communications Inc
A strategic investment partner providing capital and industry expertise to support the growth of healthcare-focused enterprises.
What's next for Springtide Child Development?
Following this major strategic investment, Springtide is expected to accelerate its geographic footprint and enhance its proprietary care delivery infrastructure. The infusion of capital will likely support the expansion of its multi-site network, allowing the firm to reach a broader demographic of families in need of specialized developmental support. As the company transitions from its initial scaling phase to a more mature enterprise-level operation, focus will likely shift toward optimizing clinical outcomes and leveraging data-driven insights to refine its therapeutic protocols, ensuring long-term sustainability in the competitive pediatric healthcare sector.
See full Springtide Child Development company page
